In the STZ-induced diabetic nephropathy model, both Nrf2+/+ and Nrf2−/− mice showed accumulation of leukocytes and macrophages in the kidney, and digitoflavone treatment significantly reduced inflammatory cell infiltration in Nrf2+/+ mice. This evidence concerns the gene NFE2L2 and diabetic kidney disease.